idex projects 3-7% adjusted EPS growth in 2025 with HST leading recovery
Q4 2024 Management View CEO Eric Ashleman highlighted strong performance in Q4 2024, with notable achievements in the Health & Science Technologies (HST) segment, including impactful projects in ...